Evidence map›Paper›PMID 40099056›Full record

ArticleCureus2025

Investigation of the Relationship Between Neutrophil/Lymphocyte, Platelet/Lymphocyte, IgA/C3, IgA/C4, and C3/C4 Ratios and Proteinuria in Patients With Immunoglobulin A (IgA) Nephropathy.

Yasemin Kirac, Murat Duranay

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yasemin KiracDepartment of Nephrology, Faculty of Medicine, Kirikkale University, Kırıkkale, TUR.
Murat DuranayDepartment of Nephrology, Ankara Training and Research Hospital, Ankara, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease, characterized by IgA-containing immune complexes in the mesangium and mesangial cell proliferation. Proteinuria is a strong indicator of the progression of chronic kidney disease. This study aimed to evaluate the relationship between systemic inflammation markers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), IgA/complement (C)3, IgA/C4, and C3/C4 ratios, and proteinuria in IgAN patients. Methods This retrospective study involved 38 patients diagnosed with IgAN between 2002 and 2011. We assessed various serum markers such as leukocyte count, NLR, PLR, C-reactive protein (CRP), C3, C4, IgA, and IgM, as well as proteinuria. The correlation between these markers and proteinuria was examined. Results The mean age of the patients was 37.8 ± 2 years, with 68.42% male. No significant correlation was found between the NLR and proteinuria (p=0.3) or CRP (p=0.3). However, a moderate positive correlation was observed between the NLR and sedimentation rate (R=0.38, p=0.07). Significant negative correlations were found between proteinuria and both urine pH (R=-0.5, p=0.002) and IgA/C4 ratio (R=-0.5, p=0.013). There were positive correlations between the PLR and C4 (R=0.45, p=0.02) and negative correlations between the PLR and IgA/C4 ratio (R=-0.56, p=0.003) and IgA/C4 and C3 (R=-0.48, p=0.008). No significant differences in proteinuria and leukocyte count were observed between the two sexes. Conclusion Although no significant relationship was found between the NLR, PLR, and proteinuria in IgAN, correlation between the IgA/C4 ratio and C4 warrants further investigations in larger studies.

Indexed as

c3c4iganneutrophil-to-lymphocyte ratioplatelet-to-lymphocyte ratioproteinuria

Identifiers

PMID40099056
PMCPMC11913522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.